News archive for Faculty of Medicine

CISMAC Annual Report 2019 – worth a read! (30.04.2020)

CISMAC has prepared its Annual Report for 2019. Highlighting the year’s activity at the Centre for Research Excellence, the report also begins to consider future directions for the Centre, after the end of the 10-year funding period.

Two MED Prizes to IGS / CIH researchers (30.04.2020)

Halvor Sommerfelt and Cecilie Svanes have been awarded the Faculty of Medicine’s Publication and Communications Prizes, respectively, for 2019.

Call for CMI-UiB Collaboration Funds 2020 (29.04.2020)

Chr. Michelsen Institute and the University of Bergen have a long-standing agreement to strengthen development-related research in Bergen. We now invite applications for collaboration between our two institutions. Deadline 20 June, 2020.

CIH’s Annual Report 2019 is published! (28.04.2020)

CIH’s Annual Report gives the Centre a chance to reflect on its activities over the past year. The Centre vision provides a “red thread” through the research, networking, education and publication activity.

Bringing Philosophy of Science to the CCBIO Table (22.04.2020)

The CCBIO International Faculty was established to support the Centre through active collaborations and strategic advice. In addition to the 13 already affiliated members, we have now recruited a new member, Marta Bertolaso from Rome, Italy, and have the pleasure of presenting her and her unique contribution to CCBIO.

Hanne Keyser Hegdahl: Young women’s sexual and reproductive health behaviour, beliefs and risks in a sub-Saharan African setting (20.04.2020)

PhD Candidate Hanne Keyser Hegdahl’s work studies factors contributing to young women’s sexual and reproductive health behaviour, attitudes, beliefs and risks in a sub-Saharan African setting.

Map position and line between Bergen and Boston

Continued support from RCN and DIKU for the CCBIO-Harvard INTPART project (17.04.2020)

CCBIO applied for and recently received continued support from the Research Council of Norway (RCN) and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (DIKU) for phase 2 of the INTPART project: “Bergen-Harvard Cancer Studies phase 2: Continued Partnership for Responsible Education, Research and Innovation Excellence.”

Mechanism of a cell motility regulator (07.04.2020)

Actin is the most abundant protein in human cells and is involved in numerous functions including steering cellular architecture, cell motility and cell division. Recently, UiB researchers identified NAA80 as a long-sought actin regulator. Now, the structure of NAA80 bound to actin and profilin reveals its mechanism of action.

Exosome-derived miRNAs in the pre-metastatic niche formation in melanoma brain metastases (02.04.2020)

Exosomes released from the primary tumour into circulation have been documented to promote pre-metastatic niche formation. We have identified a miRNA in exosomes from melanoma brain metastases that can play a vital role in this process. Knock-down (KD) of this miRNA results in an inhibition of brain metastatic growth. We are in the process of identifying potential drugs inhibiting the expression... Read more

Research Collaboration with Suzhou Institute for Brainsmatics

Studying brain tumorigenesis and brain metastasis development through high-throughput and high-resolution brain mapping (02.04.2020)

Research leaders at the Translational Cancer Research group have newly established a research collaboration with the HUST-Suzhou Institute for Brainsmatics, to study the development of brain tumors and brain metastasis.